The Endovascular Stent Grafts Market size is expected to reach US$ 2.09 Billion by 2034 from US$ 1.3 Billion in 2025. The market is estimated to record a CAGR of 6.11% from 2026 to 2034.
The increasing incidence of abdominal and thoracic aortic aneurysms, peripheral vascular diseases, and age-related cardiovascular conditions is significantly driving demand for endovascular stent grafts. Healthcare providers are increasingly adopting endovascular repair techniques because they offer less invasive alternatives to traditional open surgery, resulting in shorter hospital stays, faster recovery, and lower complication rates. Continuous improvements in vascular imaging and interventional technologies are expected to support market expansion throughout the forecast period.
Get Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00025149
Key Market Drivers
The growing prevalence of cardiovascular diseases remains one of the primary factors driving the endovascular stent grafts market. Rising cases of aortic aneurysms, arterial dissections, and vascular trauma have increased the demand for effective minimally invasive treatment solutions. An aging global population, along with lifestyle-related risk factors such as hypertension, diabetes, obesity, and smoking, continues to contribute to the growing patient population requiring vascular interventions.
Another important driver is the increasing preference for minimally invasive procedures among both physicians and patients. Endovascular stent graft placement reduces surgical trauma, minimizes blood loss, and shortens recovery time compared to conventional surgical approaches. Growing investments in advanced catheter-based technologies and expanding access to specialized vascular care further support market growth.
Technological Advancements Supporting Market Growth
Continuous technological innovation is transforming the endovascular stent grafts market through the development of more flexible, durable, and anatomically adaptable devices. Modern stent graft systems are designed to improve navigation through complex vascular anatomy while providing secure fixation and long-term durability.
Advancements in imaging guidance, including high-resolution fluoroscopy and three-dimensional vascular imaging, have enhanced procedural precision and treatment planning. Manufacturers are also focusing on lower-profile delivery systems that improve procedural efficiency and expand eligibility for minimally invasive repair in patients with challenging anatomical conditions.
Research into next-generation biomaterials and customized stent graft solutions is expected to further improve clinical outcomes while reducing the need for repeat interventions.
Applications Across Vascular Care
Endovascular stent grafts are widely used in the treatment of abdominal aortic aneurysms, thoracic aortic aneurysms, aortic dissections, traumatic vascular injuries, and other complex vascular disorders. Hospitals, cardiovascular specialty centers, and hybrid operating rooms remain the primary healthcare settings utilizing these devices.
Growing adoption of endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) procedures continues to expand clinical applications. Physicians increasingly rely on advanced stent graft technologies to manage high-risk patients who may not be suitable candidates for open surgical repair. Continuous improvements in procedural techniques are further increasing treatment success and patient safety.
Regional Market Insights
North America continues to account for a significant share of the endovascular stent grafts market due to its advanced cardiovascular care infrastructure, high adoption of minimally invasive vascular procedures, and strong presence of leading medical device manufacturers. Increasing awareness of early aneurysm diagnosis and favorable reimbursement systems continue to support regional growth.
Europe also maintains a substantial market position with well-established vascular surgery programs, advanced interventional cardiology services, and increasing adoption of innovative endovascular technologies. Meanwhile, Asia Pacific is expected to witness considerable growth owing to expanding healthcare infrastructure, rising cardiovascular disease prevalence, increasing healthcare expenditure, and growing access to advanced vascular treatments. Emerging healthcare markets across Latin America and the Middle East & Africa are gradually increasing adoption of endovascular therapies as specialized cardiovascular services continue to expand.
Competitive Landscape
The endovascular stent grafts market remains highly competitive, with leading manufacturers focusing on product innovation, clinical research, strategic partnerships, and geographic expansion. Companies continue investing in advanced device designs that improve flexibility, deployment accuracy, and long-term durability.
Research and development efforts are also directed toward expanding product portfolios for complex aortic anatomies and improving physician training through simulation technologies and clinical education programs. Strategic acquisitions and collaborations continue to strengthen competitive positioning within the global market.
Top Players
- Terumo Corporation
- Lombard Medical
- Johnson and Johnson Services, Inc.
- Cardinal Health
- Cook
- Boston Scientific Corporation
- BD
- Medtronic
- MicroPort Scientific Corporation
- Merit Medical Systems
Emerging Industry Trends
Several emerging trends are shaping the future of the endovascular stent grafts market. Personalized vascular treatment planning, supported by advanced imaging and three-dimensional modeling, is improving procedural outcomes and patient selection. The development of fenestrated and branched stent graft systems is expanding treatment options for patients with complex aneurysm anatomies.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00025149
Artificial intelligence-assisted imaging analysis, robotic-assisted vascular interventions, and enhanced navigation technologies are also improving procedural accuracy and efficiency. Additionally, ongoing research into advanced biomaterials and next-generation delivery systems is expected to further improve long-term device performance and patient outcomes.
Future Outlook
The future outlook for the endovascular stent grafts market remains highly promising as demand for minimally invasive cardiovascular procedures continues to grow worldwide. Rising prevalence of vascular diseases, expanding adoption of endovascular repair techniques, and continuous technological innovation are expected to support sustained market expansion through 2034. Increasing investments in cardiovascular healthcare infrastructure, improvements in imaging technologies, and the development of patient-specific stent graft solutions will create significant growth opportunities. As healthcare providers increasingly prioritize minimally invasive treatment approaches that improve clinical outcomes and reduce recovery time, the endovascular stent grafts market is expected to maintain steady long-term growth.
Related Reports @
Endovascular Treatment Devices Market Size, Trends & Demand by 2034
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
